Ryman Healthcare Limited

RYM

NZRYME0001S4

Healthcare Facilities & Services

End-of-day quote New Zealand S.E. Other stock markets 18:00:00 2024-05-22 EDT			5-day change	1st Jan Change
3.9 ^NZD	+2.63%		+3.45%	-33.90%

05-14	Jarden Upgrades Ryman Healthcare to Neutral from Underweight, Price Target is NZ$4.36	MT
04-22	New Zealand Shares Jumps on Business Optimism; Ryman Healthcare CEO Resigns	MT

Ryman Healthcare Appoints Jeremy Moore as Chief Development Officer

January 16, 2020 at 03:31 pm

Jeremy Moore has been appointed Chief Development Officer at Ryman Healthcare. Jeremy joined Ryman Healthcare's development team in 2012 and has been Acting Chief Development Officer since May 2019.

Latest news about Ryman Healthcare Limited

Jarden Upgrades Ryman Healthcare to Neutral from Underweight, Price Target is NZ$4.36	05-13	MT
New Zealand Shares Jumps on Business Optimism; Ryman Healthcare CEO Resigns	04-22	MT
Ryman Healthcare Group CEO Resigns	04-21	MT
Ryman Healthcare Lowers Fiscal Year 2024 Underlying Profit Guidance; Shares Fall 8%	02-18	MT
Ryman Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-29	CI
Transcript : Ryman Healthcare Limited, H1 2024 Earnings Call, Nov 29, 2023	11-28
Ryman Healthcare Limited Provides Debt Facilities Update	23-09-21	CI
Transcript : Ryman Healthcare Limited - Shareholder/Analyst Call	23-07-26
Ryman Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-19	CI
Transcript : Ryman Healthcare Limited, 2023 Earnings Call, May 19, 2023	23-05-18
New Zealand King Salmon Chairman Resigns	23-04-16	MT
New Zealand shares end at 9-1/2-month high, Australia closed (Jan 26)	23-01-25	RE
New Zealand shares inch lower in early trade, Australia closed	23-01-25	RE
Ryman Healthcare Limited Announces Interim Dividend, Payable on December 16, 2022	22-11-18	CI
Transcript : Ryman Healthcare Limited, Q2 2023 Earnings Call, Nov 18, 2022	22-11-17
Ryman Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-17	CI
Australian shares hit over 2-week high as banks shine; all eyes on U.S. inflation data	22-09-13	RE
Transcript : Ryman Healthcare Limited - Shareholder/Analyst Call	22-07-27
Ryman Healthcare Appoints Cheyne Chalmers as New Zealand CEO	22-06-06	CI
UBS Adjusts Ryman Healthcare's Price Target to NZ$10.9 From NZ$10.5, Keeps at Neutral	22-05-24	MT
Ryman Healthcare Limited Announces Final Dividend, Payable on June 17, 2022	22-05-20	CI
Ryman Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-20	CI
Transcript : Ryman Healthcare Limited, 2022 Earnings Call, May 20, 2022	22-05-19
Ryman Healthcare Plans New Village in Rolleston	22-05-19	CI
Ryman Healthcare Plans to Build A Retirement Village in Coburg North in Melbourne	22-05-19	CI

Chart Ryman Healthcare Limited

Duration

Period

More charts

Ryman Healthcare Limited is a vertically integrated retirement-living and aged-care developer, owner and operator. The Company develops, owns and operates integrated retirement villages, rest homes, and hospitals for the elderly within New Zealand and Australia. It provides a range of retirement-living options, including independent apartments and townhouses and assisted living in serviced apartments. Its aged-care offering includes rest homes, hospitals and dementia care. The Company's assisted living offers a range of services, including scheduled transport services and outings, village management and administration, maintaining and operating the community amenities, and gardening and ground maintenance and others. Its one, two and three-bedroom apartments and townhouses offer a neutral color palette. It also offers musical entertainment, fashion shows, arts and crafts, and regular outings. It owns and operates 38 villages across New Zealand and seven in Victoria, Australia.

Sector

Healthcare Facilities & Services

Calendar

2024-05-26 - Q4 2024 Earnings Call

More about the company

Income Statement Evolution

More financial data

Ratings for Ryman Healthcare Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.9 NZD

Average target price

7.266 NZD

Spread / Average Target

+86.31%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
RYMAN HEALTHCARE LIMITED	-33.90%	1.59B
HCA HEALTHCARE, INC.	+16.49%	83.4B
CVS HEALTH CORPORATION	-29.52%	72.11B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	0.00%	27.04B
LABCORP HOLDINGS INC.	-13.29%	16.96B
FRESENIUS SE & CO. KGAA	+1.03%	16.86B
QUEST DIAGNOSTICS INCORPORATED	+1.57%	15.76B
NATERA, INC.	+71.63%	13.33B
REDE D'OR SÃO LUIZ S.A.	+1.53%	12.76B
TENET HEALTHCARE CORPORATION	+70.68%	12.74B

Other Healthcare Facilities & Services

Ryman Healthcare Limited

Equities

RYM

NZRYME0001S4

Healthcare Facilities & Services

Ryman Healthcare Appoints Jeremy Moore as Chief Development Officer

Latest news about Ryman Healthcare Limited

Chart Ryman Healthcare Limited

Company Profile

Income Statement Evolution

Ratings for Ryman Healthcare Limited

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Healthcare Facilities & Services